Advanced search×

Neutral effects of the novel analgesic tapentadol on cardiac repolarization due to mixed ion channel inhibitory activities

J Schneider, U Jahnel, and K Linz

Drug Dev Res Ahead of Print:n/a (2010)

DOI: 10.1002/ddr.20360
Version: za2963e q8zad q8zb8 q8zca q8zd2 q8ze8 q8zfb q8zg6
Buy PDF

Similar articles you may find interesting…

  1. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1...
    Parker C Wilson, Mi-Hye Lee, and Ayad A Jaffa

    J Biol Chem (2013) PMID 23661707

    We find that the arrestin pathway-selective AT1 agonist, [Sar1,Ile4,Ile8]-AngII, but not the neutral AT1 antagonist, losartan, inhibits endogenous B2 receptor signaling. In a transfected HEK293 cell model that recapitulates this effect, we find that the actions of [Sar1,Ile4, Ile8]-AngII require the...
    PDF not found
  2. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.
    Jonathan Sitrin, Aaron Ring, and Diane Mathis

    J Exp Med (2013) PMID 23650440

    We have explored the molecular mechanisms underlying this NK-T reg cell axis, following leads from a kinetic exploration of gene expression changes early after punctual perturbation of T reg cells in BDC2.5/NOD mice. Results from gene signature analyses, quantification of STAT5 phosphorylation level...
    Buy PDF
  3. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic too...
    R Madrigal-Burgaleta, M P Berges-Gimeno, and E Alvarez-Cuesta

    Allergy (2013) PMID 23647576

    In the hands of a Desensitization Program, managed by drug desensitization experts, this new protocol has proven an effective therapeutic tool for hypersensitivity to several antineoplastic agents (oxaliplatin, carboplatin, paclitaxel, docetaxel, cyclophosphamide, and rituximab); moreover, it improv...
    Buy PDF